Exane Derivatives’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$617 Hold
7
﹤0.01% 553
2022
Q1
$610 Hold
7
﹤0.01% 843
2021
Q4
$676 Hold
7
﹤0.01% 742
2021
Q3
$623 Hold
7
﹤0.01% 917
2021
Q2
$614 Hold
7
﹤0.01% 923
2021
Q1
$629 Hold
7
﹤0.01% 775
2020
Q4
$551 Hold
7
﹤0.01% 732
2020
Q3
$530 Hold
7
﹤0.01% 673
2020
Q2
$581 Hold
7
﹤0.01% 602
2020
Q1
$528 Hold
7
﹤0.01% 591
2019
Q4
$638 Hold
7
﹤0.01% 590
2019
Q3
$572 Hold
7
﹤0.01% 575
2019
Q2
$577 Hold
7
﹤0.01% 590
2019
Q1
$663 Hold
7
﹤0.01% 526
2018
Q4
$640 Hold
7
﹤0.01% 594
2018
Q3
$733 Hold
7
﹤0.01% 561
2018
Q2
$778 Hold
7
﹤0.01% 546
2018
Q1
$889 Sell
7
-11,134
-100% -$1.49M ﹤0.01% 481
2017
Q4
$1.56M Sell
11,141
-2,908
-21% -$384K 0.27% 69
2017
Q3
$1.69M Buy
14,049
+14,046
+468,200% +$1.71M 0.32% 62
2017
Q2
$358 Hold
3
﹤0.01% 510
2017
Q1
$361 Sell
3
-32,716
-100% -$4M ﹤0.01% 443
2016
Q4
$4.09M Buy
+32,719
New +$4.13M 0.81% 29

Other funds holding INGR

Exane Derivatives's INGR Position: Q2 2022 in Review

Exane Derivatives held its Ingredion (INGR) position steady in Q2 2022 at 7 shares worth $617. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Exane Derivatives first reported a position in INGR in Q4 2016 and has held it in 23 quarters since. The position peaked at $4.09M in Q4 2016. 456 funds tracked by Wall St. Rank hold INGR as of Q2 2022.

  • Exane Derivatives held 7 shares of Ingredion worth $617 as of Q2 2022.
  • Exane Derivatives left its Ingredion share count unchanged in Q2 2022.
  • Ingredion made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #553 holding.
  • Exane Derivatives first reported a position in Ingredion in Q4 2016 and has held it in 23 quarters since.
  • Exane Derivatives's Ingredion position peaked at $4.09M in Q4 2016.
  • 456 funds tracked by Wall St. Rank held Ingredion as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.